Get started
Author

Antonella Borgatti

Observed names: A Borgatti, A. Borgatti, Borgatti, Antonella
ORCID: 0000-0003-1939-0611
Observed ORCID: 0000-0003-1939-0611
OpenAlex ID: A5077140922
Molecular Profiling Reveals Prognostically Significant Subtypes of Canine Lymphoma
2012 · A. M. Frantz, A. L. Sarver, et al. · Veterinary Pathology · 114
PDF
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study
2014 · Cheryl A. London, Luis Feo Bernabe, et al. · PLoS ONE · 102
PDF
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study
2015 · Cheryl A. London, Heather L. Gardner, et al. · PLoS ONE · 79
PDF
A phase I clinical study to evaluate safety of orally administered, genetically engineeredSalmonella entericaserovarTyphimuriumfor canine osteosarcoma
2016 · Sara E. Fritz, Michael S. Henson, et al. · Veterinary Medicine and Science · 64
PDF
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response
2024 · Mason J. Webb, Thanich Sangsuwannukul, et al. · Nature Communications · 58
Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study
2022 · Andi Flory, Kristina M. Kruglyak, et al. · PLoS ONE · 58
PDF
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2021 · Amy K. LeBlanc, Christina N. Mazcko, et al. · Clinical Cancer Research · 55
PDF
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2017 · Antonella Borgatti, Joseph S. Koopmeiners, et al. · Molecular Cancer Therapeutics · 54
Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma
2015 · C. Cannon, A. Borgatti, et al. · Journal of Small Animal Practice · 51
Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
2018 · Abbey R. Sadowski, Heather L. Gardner, et al. · BMC Veterinary Research · 45
PDF
Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma
2021 · Alison R. Masyr, Aaron K. Rendahl, et al. · Journal of the American Veterinary Medical Association · 32
A Tumor-Related Lymphoid Progenitor Population Supports Hierarchical Tumor Organization in Canine B-Cell Lymphoma
2011 · D. Ito, M.M. Endicott, et al. · Journal of Veterinary Internal Medicine · 28
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model
2016 · Corey Saba, Melissa Paoloni, et al. · PLoS ONE · 27
PDF
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma
2023 · Kelly M. Makielski, Aaron L. Sarver, et al. · Molecular Therapy — Oncolytics · 26
Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells
2022 · Robert Hullsiek, Yunfang Li, et al. · Frontiers in Immunology · 23
Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
2017 · Kristy Pilbeam, Hongbo Wang, et al. · Oncotarget · 23
Clinical Signs, Treatment, and Outcome in Cats with Myeloma-Related Disorder Receiving Systemic Therapy
2015 · Claire M. Cannon, Christina Knudson, et al. · Journal of the American Animal Hospital Association · 22
Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma – A pilot study
2017 · Antonella Borgatti, Amber L. Winter, et al. · PLoS ONE · 20
PDF
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
2018 · Felix Oh, Deborah Todhunter, et al. · Clinical Pharmacology Advances and Applications · 16
Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional
2019 · Antonella Borgatti, Erin B. Dickerson, et al. · Veterinary and Comparative Oncology · 11
Impact of repeated cycles of EGF bispecific angiotoxin ( eBAT ) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma
2020 · Antonella Borgatti, Ann Fieberg, et al. · Veterinary and Comparative Oncology · 10
Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients
2021 · Kristine Walters, Alessia Stornetta, et al. · BMC Veterinary Research · 9
PDF
Applicability of 3T Body MRI in Assessment of Nonfocal Bone Marrow Involvement of Hematopoietic Neoplasia in Dogs
2013 · D.A. Feeney, L.C. Sharkey, et al. · Journal of Veterinary Internal Medicine · 8
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses
2023 · Mason J. Webb, Timothy Kottke, et al. · Molecular Therapy — Oncolytics · 6
Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.
2013 · Daniel A Feeney, Leslie C Sharkey, et al. · Europe PMC (PubMed Central) · 6
Works count: 79
Citation count: 984
H-index: 18
I10-index: 21
Year
Topic
Type